Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Donohue

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Chest|February 11, 2004
Changing patterns in asbestos-induced lung diseaseJill Ohar, David A Sterling, Eugene Bleecker, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2018
Food and Drug Administration-mandated Trials of Long-Acting β-Agonist Safety in Asthma. Bang for the Buck?Samy Suissa, Elliot Israel, James Donohue, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|May 13, 2026
A nine-month survival following rupture of a juxtarenal abdominal aortic aneurysm without repairJames Donohue, Nathan Booth, Shyamal Pansuriya, et al.
Scientific Reports|April 6, 2026
Measuring the added benefits of decentralized trial elements (SHASTA): impact on enrollment, demographics, and data completeness through a single sponsorAnna Yang, Elizabeth Mandel, Seema Asthana, et al.
Respiratory Medicine|April 14, 2009
Influence of C-159T SNP of the CD14 gene promoter on lung function in smokersHaibo Zhou, Neil E Alexis, Martha Almond, et al.
Journal of Experimental Psychology. Animal Learning and Cognition|September 29, 2022
There's something about a pattern: Choice between pattern and random sequences in implicit learningCharles Locurto, James Donohue, Amy Hasenauer, et al.
Current Medical Research and Opinion|November 27, 2008
A retrospective randomized study of asthma control in the US: results of the CHARIOT studyPhilip Marcus, Renée J G Arnold, Sean Ekins, et al.
Data in Brief|September 20, 2019
Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary diseaseJames Donohue, Edward Kerwin, Sanjay Sethi, et al.
Drugs|September 13, 2014
Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPDLorraine Murphy, Stephen Rennard, James Donohue, et al.
Journal of Patient-Reported Outcomes|October 31, 2019
Responsiveness of PROMIS® to change in chronic obstructive pulmonary diseaseSusan E Yount, Charles Atwood, James Donohue, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chest|February 11, 2004
Changing patterns in asbestos-induced lung diseaseJill Ohar, David A Sterling, Eugene Bleecker, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2018
Food and Drug Administration-mandated Trials of Long-Acting β-Agonist Safety in Asthma. Bang for the Buck?Samy Suissa, Elliot Israel, James Donohue, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|May 13, 2026
A nine-month survival following rupture of a juxtarenal abdominal aortic aneurysm without repairJames Donohue, Nathan Booth, Shyamal Pansuriya, et al.
Scientific Reports|April 6, 2026
Measuring the added benefits of decentralized trial elements (SHASTA): impact on enrollment, demographics, and data completeness through a single sponsorAnna Yang, Elizabeth Mandel, Seema Asthana, et al.
Respiratory Medicine|April 14, 2009
Influence of C-159T SNP of the CD14 gene promoter on lung function in smokersHaibo Zhou, Neil E Alexis, Martha Almond, et al.
Journal of Experimental Psychology. Animal Learning and Cognition|September 29, 2022
There's something about a pattern: Choice between pattern and random sequences in implicit learningCharles Locurto, James Donohue, Amy Hasenauer, et al.
Current Medical Research and Opinion|November 27, 2008
A retrospective randomized study of asthma control in the US: results of the CHARIOT studyPhilip Marcus, Renée J G Arnold, Sean Ekins, et al.
Data in Brief|September 20, 2019
Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary diseaseJames Donohue, Edward Kerwin, Sanjay Sethi, et al.
Drugs|September 13, 2014
Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPDLorraine Murphy, Stephen Rennard, James Donohue, et al.
Journal of Patient-Reported Outcomes|October 31, 2019
Responsiveness of PROMIS® to change in chronic obstructive pulmonary diseaseSusan E Yount, Charles Atwood, James Donohue, et al.
Pageof 2